These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
291 related articles for article (PubMed ID: 35887159)
21. Therapeutic Potential of TAAR1 Agonists in Schizophrenia: Evidence from Preclinical Models and Clinical Studies. Dedic N; Dworak H; Zeni C; Rutigliano G; Howes OD Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34947997 [TBL] [Abstract][Full Text] [Related]
22. Potential of Ligands for Trace Amine-Associated Receptor 1 (TAAR1) in the Management of Substance Use Disorders. Wu R; Li JX CNS Drugs; 2021 Dec; 35(12):1239-1248. PubMed ID: 34766253 [TBL] [Abstract][Full Text] [Related]
24. Non-fibrillar beta-amyloid abates spike-timing-dependent synaptic potentiation at excitatory synapses in layer 2/3 of the neocortex by targeting postsynaptic AMPA receptors. Shemer I; Holmgren C; Min R; Fülöp L; Zilberter M; Sousa KM; Farkas T; Härtig W; Penke B; Burnashev N; Tanila H; Zilberter Y; Harkany T Eur J Neurosci; 2006 Apr; 23(8):2035-47. PubMed ID: 16630051 [TBL] [Abstract][Full Text] [Related]
25. Role of trace amine‑associated receptor 1 in the medial prefrontal cortex in chronic social stress-induced cognitive deficits in mice. Zhang Y; Li JT; Wang H; Niu WP; Zhang CC; Zhang Y; Wang XD; Si TM; Su YA Pharmacol Res; 2021 May; 167():105571. PubMed ID: 33753244 [TBL] [Abstract][Full Text] [Related]
26. Normal thermoregulatory responses to 3-iodothyronamine, trace amines and amphetamine-like psychostimulants in trace amine associated receptor 1 knockout mice. Panas HN; Lynch LJ; Vallender EJ; Xie Z; Chen GL; Lynn SK; Scanlan TS; Miller GM J Neurosci Res; 2010 Jul; 88(9):1962-9. PubMed ID: 20155805 [TBL] [Abstract][Full Text] [Related]
27. Amyloid beta peptide 1-42 disturbs intracellular calcium homeostasis through activation of GluN2B-containing N-methyl-d-aspartate receptors in cortical cultures. Ferreira IL; Bajouco LM; Mota SI; Auberson YP; Oliveira CR; Rego AC Cell Calcium; 2012 Feb; 51(2):95-106. PubMed ID: 22177709 [TBL] [Abstract][Full Text] [Related]
28. Trace Amines and the Trace Amine-Associated Receptor 1: Pharmacology, Neurochemistry, and Clinical Implications. Pei Y; Asif-Malik A; Canales JJ Front Neurosci; 2016; 10():148. PubMed ID: 27092049 [TBL] [Abstract][Full Text] [Related]
32. Tripchlorolide improves cognitive deficits by reducing amyloid β and upregulating synapse-related proteins in a transgenic model of Alzheimer's Disease. Zeng Y; Zhang J; Zhu Y; Zhang J; Shen H; Lu J; Pan X; Lin N; Dai X; Zhou M; Chen X J Neurochem; 2015 Apr; 133(1):38-52. PubMed ID: 25661995 [TBL] [Abstract][Full Text] [Related]
33. Inhibition of protease-activated receptor 1 (PAR1) ameliorates cognitive performance and synaptic plasticity impairments in animal model of Alzheimer's diseases. Zare D; Rajizadeh MA; Maneshian M; Jonaidi H; Sheibani V; Asadi-Shekaari M; Yousefi M; Esmaeilpour K Psychopharmacology (Berl); 2021 Jun; 238(6):1645-1656. PubMed ID: 33624157 [TBL] [Abstract][Full Text] [Related]
34. TAAR1 agonist ulotaront modulates striatal and hippocampal glutamate function in a state-dependent manner. Yang SM; Ghoshal A; Hubbard JM; Gackière F; Teyssié R; Neale SA; Hopkins SC; Koblan KS; Bristow LJ; Dedic N Neuropsychopharmacology; 2024 Jun; 49(7):1091-1103. PubMed ID: 38110609 [TBL] [Abstract][Full Text] [Related]
35. AMPA-ergic regulation of amyloid-β levels in an Alzheimer's disease mouse model. Hettinger JC; Lee H; Bu G; Holtzman DM; Cirrito JR Mol Neurodegener; 2018 May; 13(1):22. PubMed ID: 29764453 [TBL] [Abstract][Full Text] [Related]
36. Brain-specific overexpression of trace amine-associated receptor 1 alters monoaminergic neurotransmission and decreases sensitivity to amphetamine. Revel FG; Meyer CA; Bradaia A; Jeanneau K; Calcagno E; André CB; Haenggi M; Miss MT; Galley G; Norcross RD; Invernizzi RW; Wettstein JG; Moreau JL; Hoener MC Neuropsychopharmacology; 2012 Nov; 37(12):2580-92. PubMed ID: 22763617 [TBL] [Abstract][Full Text] [Related]